Drusen with accompanying fluid underneath the sensory retina.
暂无分享,去创建一个
Maciej Wojtkowski | Bartosz L Sikorski | Maciej Szkulmowski | Andrzej Kowalczyk | Danuta Bukowska | M. Wojtkowski | A. Kowalczyk | D. Bukowska | M. Szkulmowski | Jakub J Kaluzny | J. Kałużny | B. Sikorski
[1] G. Ravera,et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.
[2] P. Keane,et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[3] Richard F Spaide,et al. COMPARISON OF FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY FOR PATIENTS WITH CHOROIDAL NEOVASCULARIZATION AFTER PHOTODYNAMIC THERAPY , 2005, Retina.
[4] Maciej Wojtkowski,et al. Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. , 2008, Investigative ophthalmology & visual science.
[5] Maciej Wojtkowski,et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. , 2006, Ophthalmology.
[6] Miguel J Maldonado,et al. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. , 2005, American journal of ophthalmology.
[7] Sumit Sharma,et al. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. , 2009, Ophthalmology.
[8] Irene Barbazetto,et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. , 2003, Archives of ophthalmology.
[9] Ronald Klein,et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.
[10] Carmen A Puliafito,et al. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. , 2002, American journal of ophthalmology.
[11] J. Caprioli,et al. Optical coherence tomography to detect and manage retinal disease and glaucoma. , 2004, American journal of ophthalmology.
[12] W R Green,et al. Senile macular degeneration: a histopathologic study. , 1977, Transactions of the American Ophthalmological Society.
[13] Paul Mitchell,et al. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. , 2003, Archives of ophthalmology.
[14] J. Duker,et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.
[15] Iwona Gorczynska,et al. Comparison of reflectivity maps and outer retinal topography in retinal disease by 3-D Fourier domain optical coherence tomography. , 2009, Optics express.
[16] Anna Szkulmowska,et al. Analysis of posterior retinal layers in spectral optical coherence tomography images of the normal retina and retinal pathologies. , 2007, Journal of biomedical optics.
[17] Edoardo Midena,et al. Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration , 2007, British Journal of Ophthalmology.
[18] W. Green,et al. IRON TOXICITY AS A POTENTIAL FACTOR IN AMD , 2007, Retina.
[19] S. Kishi,et al. Elongation of photoreceptor outer segment in central serous chorioretinopathy. , 2008, American journal of ophthalmology.
[20] M. Wojtkowski,et al. Correlation of spectral optical coherence tomography with fluorescein and indocyanine green angiography in multiple evanescent white dot syndrome , 2008, British Journal of Ophthalmology.
[21] J. Slakter,et al. Indocyanine-green videoangiography of drusen as a possible predictive indicator of exudative maculopathy. , 1998, Ophthalmology (Rochester, Minn.).
[22] Gabriel Coscas,et al. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. , 2007, American journal of ophthalmology.
[23] C. Puliafito,et al. Optical Coherence Tomography in the Diagnosis and Management of Posterior Segment Disorders , 2001 .
[24] James G. Fujimoto,et al. Optical Coherence Tomography of Ocular Diseases , 1995 .
[25] S. Harding,et al. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study , 2005, British Journal of Ophthalmology.
[26] J M Seddon,et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration , 2008, British Journal of Ophthalmology.
[27] R. Brancato,et al. Hyperfluorescent plaque lesions in the late phases of indocyanine green angiography: a possible contraindication to the laser treatment of drusen. , 1997, American journal of ophthalmology.
[28] J. Duker,et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. , 2005, Ophthalmology.
[29] Geoffrey P Lewis,et al. Drusen-associated degeneration in the retina. , 2003, Investigative ophthalmology & visual science.
[30] Sina Farsiu,et al. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. , 2009, Ophthalmology.
[31] B. Bouma,et al. Handbook of Optical Coherence Tomography , 2001 .
[32] E Reichel,et al. Optical coherence tomography of central serous chorioretinopathy. , 1995, American journal of ophthalmology.
[33] G. Gilkeson,et al. Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. , 2007, Investigative Ophthalmology and Visual Science.
[34] Joseph A Izatt,et al. CORRELATION OF PATHOLOGIC FEATURES IN SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY WITH CONVENTIONAL RETINAL STUDIES , 2008, Retina.
[35] Maciej Wojtkowski,et al. Analysis of the outer retina reconstructed by high-resolution, three-dimensional spectral domain optical coherence tomography. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[36] A. Hofman,et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.
[37] S. J. Talks,et al. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes , 2005, British Journal of Ophthalmology.
[38] Justine R. Smith,et al. CCR3 is a therapeutic and diagnostic target for neovascular age-related macular degeneration , 2009, Nature.